Signal active
Organization
Contact Information
Overview
Waterstone Pharmaceuticals is a private US based company with research, development & manufacturing capabilities in Wuhan, China. Waterstone Pharmaceuticals engages in activities ranging from drug discovery of proprietary new chemical entities, custom development & manufacturing services, and generic drug development and manufacturing.
About
Biotechnology, Health Care, Pharmaceutical
2008
501-1000
Headquarters locations
Asia
Social
N/A
Profile Resume
Waterstone Pharmaceuticals headquartered in Asia, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $537.4M in funding across 24 round(s). With a team of 501-1000 employees, Waterstone Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Waterstone Pharmaceuticals, raised $3.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
2
2
0
$22.4M
Details
1
Waterstone Pharmaceuticals has raised a total of $22.4M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2012 | Early Stage Venture | 3.4M |
Investors
Waterstone Pharmaceuticals is funded by 3 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Acorn Campus Ventures | - | FUNDING ROUND - Acorn Campus Ventures | 3.4M |
Waterstone Pharmaceuticals | - | FUNDING ROUND - Waterstone Pharmaceuticals | 3.4M |
Burrill & Company | - | FUNDING ROUND - Burrill & Company | 3.4M |
Recent Activity
There is no recent news or activity for this profile.